Ftse Mib
34.704,40
0,61%
DAX
18.608,16
0,68%
S&P 500
5.248,38
-0,55%
NASDAQ
16.701,33
-0,20%
Bitcoin
69.199,97
2,14%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Codexis Inc (CDXS) Codexis Inc (CDXS) Notizie

Codexis Inc

CDXS
3,3414
-0,0386 (-1,14%)
Ultimo aggiornamento: 18:19:28
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/5/202422:25GLOBECodexis to Participate in Jefferies Global Healthcare..
20/5/202422:05GLOBECodexis to Participate in TD Cowen 2nd Annual Sustainability..
14/5/202415:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/5/202412:52EDGAR2Form 8-K - Current report
14/5/202412:00GLOBECodexis Presents Groundbreaking Enzymatic Synthesis Data at..
02/5/202422:05GLOBECodexis Reports First Quarter 2024 Financial Results
18/4/202422:05GLOBECodexis to Report First Quarter 2024 Financial Results on..
11/4/202413:05GLOBECodexis Appoints Carole Cobb, MBA, to Strategic Advisory..
06/3/202422:02EDGAR2Form 8-K - Current report
28/2/202422:05GLOBECodexis Reports Fourth Quarter and Fiscal Year 2023..
27/2/202418:15APSBiotech Rallied Strongly On Exclusive Licensing Agreement
26/2/202422:05GLOBECodexis Enters Exclusive Licensing Agreement for Newly..
26/2/202414:05GLOBECodexis to Participate in TD Cowen 44th Annual Health Care..
20/2/202414:05GLOBECodexis Announces Appointment of Masad Damha, PhD, and Jim..
16/2/202422:01EDGAR2Form 8-K - Current report
14/2/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05GLOBECodexis to Report Fourth Quarter and Fiscal Year 2023..
13/2/202422:19EDGAR2Form 8-K - Current report
13/2/202422:05GLOBECodexis Secures $40 Million in Strategic Financing Deal with..
09/2/202422:06EDGAR2Form 8-K - Current report
01/2/202422:05GLOBEseqWell and Codexis to Unveil Engineered Transposase Enzyme..
24/1/202420:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202414:30EDGAR2Form 8-K - Current report
03/1/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202314:30GLOBECodexis Announces Purchase Agreement with Nestlé Health..
27/12/202314:30EDGAR2Form 8-K - Current report
13/12/202322:06GLOBECodexis and Aldevron Enter Exclusive Licensing Agreement for..
13/12/202322:05GLOBECodexis Announces Achievement of Gram-scale Synthesis with..
11/12/202313:05GLOBECodexis KOL Event Highlights Significant Need for an..
28/11/202322:05GLOBECodexis to Host Virtual KOL Event on its ECO Synthesis™..
17/11/202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:31EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:05GLOBECodexis to Participate in 35th Annual Piper Sandler..
03/11/202321:26EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202321:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:16EDGAR2Form 8-K - Current report
02/11/202321:05GLOBECodexis Reports Third Quarter 2023 Financial Results
31/10/202321:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
27/10/202321:35GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
26/10/202322:05GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
19/10/202322:05GLOBECodexis to Report Third Quarter 2023 Financial Results on..
29/9/202313:05GLOBECodexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton..
22/9/202322:32EDGAR2Form 8-K - Current report
18/9/202322:05GLOBECodexis CEO Stephen Dilly Named as Finalist of 2023 Bloom..
12/9/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 3,45 Min: 3,34 Max: 3,4687
Chiusura: 3,38

La tua Cronologia

NASDAQ
CDXS
Codexis
BIT
P1KUG5
BNP Paribas Issuance
BIT
P1PJ95
BNP Paribas Issuance
NASDAQ
BRLC
TSXV
LMR
Lomiko Metals
BIT
P1KEG9
BNP Paribas Issuance
USOTC
ANDR
Andrea Electronics (CE)
ASX
AULOG
Austar Gold
USOTC
VNRFY
Vienna Insurance (PK)
BIT
UC63HR
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network